Patent ID: 6429219
Filing Date: 2002-08-06
Classification: A61K

Abstract:
A method for the treatment of a subject suffering from a condition selected from the group consisting of chronic essential hypertension, cerebral vascular disease, chronic open angle glaucoma, macular degeneration, acute and chronic inflammation, acute and chronic inflammation, Alzheimer's disease, atherosclerosis, diabetes mellitus and insulin resistance, impotency, coronary artery disease, aging, and Parkinson's disease, said method comprising administering to said subject an amount effective in ameliorating said condition of a metal complex of the formula[A]MX whereinA is a member selected from the group consisting of L-cysteine, N-acetyl L-cysteine, L-2-oxothiazolidine-4-carboxylate, and N-(2-mercaptopropionyl)glycine, M is a metal ion selected from the group consisting of Mg+2, Cu+2, Znâˆ’2 and Se+2, and X is an anion selected from the group consisting of hydroxide, halide, acetate, ascorbate and bis-ascorbate.